Skip to content

Novel Photosensitizer in The Treatment of Chronic Periodontitis

Clinical Effects of a Single Application of a Novel Photosensitizer in The Treatment of Chronic Periodontitis - A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04374383
Enrollment
26
Registered
2020-05-05
Start date
2019-06-01
Completion date
2021-11-30
Last updated
2020-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Alveolar Bone Loss

Brief summary

The aim of this study is to evaluate the periodontal outcomes after applying antimicrobial photodynamic therapy with a novel photosensitizer as compared to LASER assisted scaling and root planing alone.

Detailed description

LASER assisted SRP followed by antimicrobial photodynamic therapy with a novel photosensitizer dye Phthalocyanine will be done in test group subjects.

Interventions

DRUGPhthalocyanine Dye

following LASER assisted SRP, a novel photosensitizer phthalocyanine dye will be placed

LASER assisted SRP will be carried

Sponsors

SVS Institute of Dental Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Systemically healthy male and female patients of age 30-60 years with generalized probing pocket depths (PPD) indicative of chronic periodontitis and with atleast two sites with PPD ≥5mm in each quadrant

Exclusion criteria

* Medically compromised patients, Subjects with a history of periodontal intervention within 6 months of the commencement of the study and smokers

Design outcomes

Primary

MeasureTime frameDescription
Release profile of the drugChange from baseline to 7-days.Release profile of the drug in Gingival Crevicular Fluid (GCF) samples will be evaluated through biochemical testing kits.
probing pocket depths (PPD)Change from baseline to 6-months.Assessment of probing pocket depths (PPD, in mm) by using a manual periodontal probe on six sites (mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual and distolingual) will be performed.
clinical attachment level (CAL)Change from baseline to 6-months.Assessment of clinical attachment level (CAL, in mm) by using a manual periodontal probe on six sites (mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual and distolingual) will be performed.

Secondary

MeasureTime frameDescription
plaque index (PI)Change from baseline to 6-months.Assessment of plaque (PI) - according to Turesky modification of Quigley and Hein Plaque Index; 0-No plaque 1-Isolated flecks of plaque at the gingival margin 2-A continuous band of plaque up to 1mm at the gingival margin 3-Plaque greater than 1mm in width and covering up to one third of the tooth surface 4-Plaque covering from one thirds to two thirds of the tooth surface 5-Plaque covering more than two thirds of the tooth surface.
bleeding on probing (BOP)Change from baseline to 6-months.Assessment of bleeding on probing (BOP) as a dichotomous variable (Yes/No) by using a manual periodontal probe.

Countries

India

Contacts

Primary ContactRVchandra, MDS; DNB
viswachandra@hotmail.com9908183071

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026